Prognosis in Therapy-Related Acute Myeloid Leukemia and Impact of Karyotype

This publication has 7 references indexed in Scilit:

• Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML
  Leukemia, 2003
• Secondary Myeloid Leukemia and Myelodysplastic Syndromes in Patients Treated for Hodgkin’s Disease: A Report From the German Hodgkin’s Lymphoma Study Group
  Journal of Clinical Oncology, 2003
• Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series
  Blood, 2003
• Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001
  Leukemia, 2002
• Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors
  Blood, 2002
• 21q22 balanced chromosome aberrations in therapy‐related hematopoietic disorders: Report from an International Workshop†
  Genes, Chromosomes and Cancer, 2002
• Balanced chromosome abnormalities inv(16) and t(15;17) in therapy‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop†
  Genes, Chromosomes and Cancer, 2002